Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels to Verigene Blood Culture in Gram-negative Bloodstream Infections using DOOR-MAT Analysis

Three RDT platforms (Verigene BC-GN, BioFire® BCID, and BCID 2 (RUO)) were compared using the Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR -MAT) to evaluate potential downstream antimicrobial prescribing decisions resulting from the panels different organism and resistance detection. BioFire BCID (RUO) had the best mean DOOR-MAT scores.

Primary Author

Claeys,Kimberly C.

Schlaffer,Kathryn

Smith,Richard

Hitchcock,Stephanie

Jiang,Yunyun

Evans,Scott

Johnson,J. Kristie

Leekha,Surbhi

URL

https://www.ncbi.nlm.nih.gov/pubmed/33772269

PMID

33772269

Reference Type

Journal Article

Periodical Full

Clinical infectious diseases

Publication Year

2021

Publication Date

Mar 27,

Place of Publication

United States

ISSN/ISBN

1058-4838

Document Object Index

10.1093/cid/ciab262